Below are the database queries which are used to create this measure. These are run against a copy of the BSA prescribing data which we store in Google BigQuery. We're working on making our BigQuery tables publicly available at which point it will be possible to run and modify these queries yourself. But even where code and database queries are not directly useable by others we believe it is always preferable to make them public.
| Description | Insulin detemir items per 1000 patients |
|---|---|
| Why it matters | Novo Nordisk are discontinuing all formulations of Levemir®, the only insulin detemir product available in the UK, with supply due to exhaust by December 2026. The Primary Care Diabetes & Obesity Society (PCDOS) and Association of British Clinical Diabetologists (ABCD) have written guidance to support clinicians in selecting and safely initiating alternative basal insulins. The guidance recommends local teams diversify prescribing across available options to reduce supply risk, and with significant regional variation in prescribing recommend he use of data to support planning. This OpenPrescribing measure, alongside it’s OpenPrescribing Hospitals counterpart provides data on variation across primary and secondary care to support this planning. |
| Tags | |
| Implies cost savings | No |
| History | View change history on GitHub → |
SELECT
CAST(month AS DATE) AS month,
practice AS practice_id,
SUM(items) AS numerator
FROM hscic.normalised_prescribing
WHERE bnf_code IN ("0601012X0AAAAAA", "0601012X0AAABAB", "0601012X0BBAAAA", "0601012X0BBABAB", "0601012X0BBACAB")
GROUP BY month, practice_idSELECT
CAST(month AS DATE) AS month,
practice AS practice_id,
SUM(total_list_size / 1000.0) AS denominator
FROM hscic.practice_statistics
GROUP BY month, practice_id